Form 4: Disc Medicine Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Rahul Khara, Chief Legal Officer of Disc Medicine, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 18, 2025, Rahul Khara, the Chief Legal Officer of Disc Medicine, Inc., sold 1,161 shares of common stock at a price of $54.58 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on January 10, 2024.
- This transaction is described as a 'sell to cover' and not a discretionary transaction.
- Following the reported transaction, Khara still beneficially owns 37,583 shares of Disc Medicine, Inc.
- This total includes shares purchased through the company's Employee Stock Purchase Plan on January 31, 2024, July 31, 2024 and January 31, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock sale for tax purposes, which is neither particularly positive nor negative.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| January 10, 2024 | Date of grant for restricted stock units that triggered the tax withholding obligation. |
| January 31, 2024 | Date of purchase of shares pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan. |
| July 31, 2024 | Date of purchase of shares pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan. |
| January 31, 2025 | Date of purchase of shares pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan. |
| February 18, 2025 | Date of the stock sale transaction. |
| February 20, 2025 | Date of signature on the Form 4 filing. |
Keywords
Disc Medicine, Rahul Khara, Form 4, Insider Trading, Stock Sale, Tax Withholding, IRON, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.